Insider Selling: Intuitive Surgical (NASDAQ:ISRG) SVP Sells $1,177,882.16 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $495.20, for a total value of $320,889.60.
• On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total transaction of $316,288.80.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00.

Intuitive Surgical Stock Down 1.3%

ISRG opened at $490.16 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The company has a 50 day moving average of $521.64 and a two-hundred day moving average of $512.28. The company has a market cap of $174.07 billion, a P/E ratio of 62.12, a P/E/G ratio of 3.78 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. lifted its stake in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $25,000. Tobam increased its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $27,000. Finally, Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. Truist Financial raised their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. Citigroup reiterated a “neutral” rating and issued a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Piper Sandler reiterated an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Wells Fargo & Company boosted their price target on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Finally, Royal Bank Of Canada upped their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.